Browse By: Country ι Category ι Tag

Breast Cancer Market Research Reports

Predictive Breast Cancer Gene Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Predictive gene testing mentors are used to detect disease or disorder inherited by analyzing gene mutations associated with particular inherited disease or disorder. Predictive gene testing is also known as presymptomatic testing due to the fact that this test is performed even before the early signs of the disease or disorder are observed and thus enable determining person’s risk of suffering disease or disorder.Predictive breast cancer gene testing is performed to identify risk of breast cancer in a person having a family history of breast cancer.  Early detection of breast cancer enables complete cure of the patient and saving affected breast of the patient. Considering the advantages of early detection of breast cancer, governments worldwide have started tak
Published Date: Dec 2022
Published By: Transparency

Price: $5795
China Breast Cancer Therapeutics Drugs Market Research Report 2017
Sales, means the sales volume of Breast Cancer Therapeutics Drugs Revenue, means the sales value of Breast Cancer Therapeutics Drugs This report studies Breast Cancer Therapeutics Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering Bayer HealthCare Eli Lily Pfizer Novartis Eisai Halozyme Therapeutics Roche Puma Biotechnology Janssen Biotech AbbVie BioMarin Array BioPharma Merck Syndax MacroGenics Market Segment by Regions (provinces), covering South China East China Southwest China Northeast China North China Central China Northwest China Split by product Type, with production, revenue, price, ma
Published Date: Feb 2017
Published By: QYResearch

Price: $3200
Europe Breast Cancer Therapeutics Drugs Market Report 2017
Sales, means the sales volume of Breast Cancer Therapeutics Drugs Revenue, means the sales value of Breast Cancer Therapeutics Drugs This report studies sales (consumption) of Breast Cancer Therapeutics Drugs in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering Bayer HealthCare Eli Lily Pfizer Novartis Eisai Halozyme Therapeutics Roche Puma Biotechnology Janssen Biotech AbbVie BioMarin Array BioPharma Merck Syndax MacroGenics Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth
Published Date: Feb 2017
Published By: QYResearch

Price: $3900
United States Breast Cancer Therapeutics Drugs Market Report 2017
Sales, means the sales volume of Breast Cancer Therapeutics Drugs Revenue, means the sales value of Breast Cancer Therapeutics Drugs This report studies sales (consumption) of Breast Cancer Therapeutics Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Bayer HealthCare Eli Lily Pfizer Novartis Eisai Halozyme Therapeutics Roche Puma Biotechnology Janssen Biotech AbbVie BioMarin Array BioPharma Merck Syndax MacroGenics Market Segment by States, covering California Texas New York Florida Illinois Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Mitotic Inhibitors
Published Date: Feb 2017
Published By: QYResearch

Price: $3800
Global Breast Cancer Therapeutics Drugs Sales Market Report 2017
Sales, means the sales volume of Breast Cancer Therapeutics Drugs Revenue, means the sales value of Breast Cancer Therapeutics Drugs This report studies sales (consumption) of Breast Cancer Therapeutics Drugs in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Bayer HealthCare Eli Lily Pfizer Novartis Eisai Halozyme Therapeutics Roche Puma Biotechnology Janssen Biotech AbbVie BioMarin Array BioPharma Merck Syndax MacroGenics Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Brea
Published Date: Feb 2017
Published By: QYResearch

Price: $4000
Global Breast Cancer Industry 2017, Trends and Forecast Report
The report firstly introduced the Breast Cancer basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Breast Cancer Market; 3.) the North American Breast Cancer Market; 4.) the European Breast Cancer Market; 5.) market entry and investment feasibility; 6.) the report conclusion.
Published Date: Feb 2017
Published By: 9Dimen Research

Price: $2850
Global Breast Cancer Market: Industry Analysis & Outlook (2017-2021)
Breast cancer’ defines a malignant tumor that has developed from cells in the breast. Some breast cancers are called in situ as they are confined within the ducts (ductal carcinoma in situ or DCIS) or lobules (lobular carcinoma in situ or LCIS) where they originated. Although, less commonly, breast cancer can also instigate in the stromal tissues, which include the fatty and fibrous connective tissues of the breast. In the early stages, breast cancer may not cause any symptoms. 
Published Date: Feb 2017
Published By: Koncept Analytics

Price: $800
Estrogen Receptor Positive (ER+) Breast Cancer - Treatment Landscape & Competitive Analysis, 2017
This report provides the insights of the marketed drugs for the Estrogen Receptor Positive (ER+) Breast Cancer which includes the Targeted Therapy, Hormone Therapy and Chemotherapy. In case of Estrogen Receptor Positive (ER+) Breast Cancer, Hormone therapy is the main focus of treatment after surgery and chemotherapy. Hormonal therapy is usually recommended after 5 years of surgery and can be divided into Estrogen blocking hormonal therapy and estrogen lowering hormonal therapy based on the mechanism of action of the hormonal therapy drugs. Of all the late-stage pipeline drugs, Buparlisib is expected to reach the market in the next few years. Recent report of DelveInsight covers the treatment landscape which provides the treatment options by different stages and type of the breast cancer.
Published Date: Feb 2017
Published By: DelveInsight

Price: $2450
Global Breast Cancer Therapeutics Drugs Market Research Report 2017
Production, means the output of Breast Cancer Therapeutics Drugs Revenue, means the sales value of Breast Cancer Therapeutics Drugs This report studies Breast Cancer Therapeutics Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Bayer HealthCare Eli Lily Pfizer Novartis Eisai Halozyme Therapeutics Roche Puma Biotechnology Janssen Biotech AbbVie BioMarin Array BioPharma Merck Syndax MacroGenics Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Br
Published Date: Feb 2017
Published By: QYResearch

Price: $2900
Global Breast Cancer Partnering 2010 to 2017
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: Feb 2017
Published By: Current Partnering

Price: $1495
Global Hghly Metastatic Breast Cancer Industry 2017, Trends and Forecast Report
The report firstly introduced the Hghly Metastatic Breast Cancer basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Hghly Metastatic Breast Cancer Market; 3.) the North American Hghly Metastatic Breast Cancer Market; 4.) the European Hghly Metastatic Breast Cancer Market; 5.) market entry and inve
Published Date: Jan 2017
Published By: 9Dimen Research

Price: $2850
Global Lung Metastatic Breast Cancer Industry 2017, Trends and Forecast Report
The report firstly introduced the Lung Metastatic Breast Cancer basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Lung Metastatic Breast Cancer Market; 3.) the North American Lung Metastatic Breast Cancer Market; 4.) the European Lung Metastatic Breast Cancer Market; 5.) market entry and investme
Published Date: Jan 2017
Published By: 9Dimen Research

Price: $2850
Global Metastatic Breast Cancer Industry 2017, Trends and Forecast Report
The report firstly introduced the Metastatic Breast Cancer basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Metastatic Breast Cancer Market; 3.) the North American Metastatic Breast Cancer Market; 4.) the European Metastatic Breast Cancer Market; 5.) market entry and investment feasibility; 6.)
Published Date: Jan 2017
Published By: 9Dimen Research

Price: $2850
Hormone Refractory Breast Cancer-Pipeline Insights, 2017
DelveInsight’s, “ Hormone Refractory Breast Cancer-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Hormone Refractory Breast Cancer. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Hormone Refractory Breast Cancer. DelveInsight’s Report
Published Date: Jan 2017
Published By: DelveInsight

Price: $1250
Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s Report, “Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Breast Cancer Report is to understand the market and pipeline status of the drugs around the Breast Cancer to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Breast Cancer. While the leading brands, c
Published Date: Jan 2017
Published By: DelveInsight

Price: $2000
Hormone Refractory Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s Report, “Hormone Refractory Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hormone Refractory Breast Cancer Report is to understand the market and pipeline status of the drugs around the Hormone Refractory Breast Cancer to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the dr
Published Date: Jan 2017
Published By: DelveInsight

Price: $2000
Metastatic Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s Report, “Metastatic Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Metastatic Breast Cancer Report is to understand the market and pipeline status of the drugs around the Metastatic Breast Cancer to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Metastati
Published Date: Jan 2017
Published By: DelveInsight

Price: $2000
Breast Cancer-API Insights, 2017
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positioned
Published Date: Jan 2017
Published By: DelveInsight

Price: $1250
Breast Cancer - Pipeline Review, H2 2016
Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Breast Cancer – Pipeline Review, H2 2016, provides an overview of the Breast Cancer (Oncology) pipeline landscape. Breast cancer is a cancer that develops from breast cells. Breast cancer usually starts off in the inner lining of milk ducts or the lobules that supply them with milk. Risk factors of breast cancer includes age, beginning of periods before the age of twelve or going through menopause after the age of fifty-five, being overweight, using hormone replacement therapy, consumption of birth control pills and consumption of alcohol. Symptoms include a lump in the breast, a change in size or shape of the breast or discharge from a nipple. Treatment includes radiation, lumpectomy, mastect
Published Date: Dec 2016
Published By: Global Markets Direct

Price: $2500
Global Breast Cancer Screening Devices Market Research Report 2016
Production, means the output of Breast Cancer Screening Devices Revenue, means the sales value of Breast Cancer Screening Devices This report studies Breast Cancer Screening Devices in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Braster ... Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Breast Cancer Screening Devices in these regions, from 2011 to 2021 (forecast), like North America Europe China Japan Southeast Asia India Split by product type, with production, revenue, price, mark
Published Date: Dec 2016
Published By: QYResearch

Price: $2900

Upcoming Reports

Wheelchair Accessible Vehicle Converters Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Vehicles which are converted in a way that have easy access for wheelchairs are termed as wheelchair accessible vehicles or WAV’s. The vehicles are specially converted from a standard vehicle to WAV in order to accommodate the wheelchair. Wheelchair accessible vehicles are considered as mult
Published By: Transparency
Price: $5795
Enteral Nutrition Pumps Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Enteral nutrition pumps also known as enteral feeding pumps are used to deliver nutritious foods containing carbohydrate, protein, fat, vitamin, minerals and water by inserting directly into the stomach or parts of small intestine. Enteral nutrition pumps are recommended to patients suffering from
Published By: Transparency
Price: $5795
Residential Water Treatment Equipment Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2014 - 2020
Increasing industrial and environmental pollution around the world is increasing the need for water treatment. Water pollution due to increasing industrialization and environment pollution is leading to death and spread of diseases. It also adversely affects more than 1 billion of population every
Published By: Transparency
Price: $5795
Steam Boiler System Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast 2014 - 2020
The growing need of effective heating systems as well as the requirement of increasing operating efficiency of residential and commercial complexes has led to the widespread adoption of steam boiler systems. This technology provides high steam temperature and improved pressure parameters to achiev
Published By: Transparency
Price: $5795
Seismic Survey Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast 2014 - 2020
Increasing exploration activities owing to the efforts of oil and gas companies to locate new oil and gas reserves is expected to drive the global seismic survey market during the forecast period. Oil and gas companies use seismic surveys to map and interpret potential petroleum reserves.  P
Published By: Transparency
Price: $5795

Back To Top